https://jason-als.org/research/a-clinical-risk-score-does-not-replace-neurofilament-testing-for-sorting-trial-participants/2026-11-01weekly0.7https://jason-als.org/research/flail-arm-survival-advantage-tracks-the-type-of-nerve-damage-not-the-arm-itself/2026-11-01weekly0.7https://jason-als.org/research/vienna-clinic-reports-longer-survival-after-switching-to-specialised-als-care/2026-11-01weekly0.7https://jason-als.org/research/pooled-data-confirm-the-gold-coast-criteria-catch-more-als-cases-with-less-certain-specificity/2026-11-01weekly0.7https://jason-als.org/research/genetic-ftd-study-motor-symptoms-not-the-gene-itself-shape-survival/2026-11-01weekly0.7https://jason-als.org/research/mouse-study-points-to-repeat-proteins-as-the-main-harm-in-c9orf72-als/2026-11-01weekly0.7https://jason-als.org/research/low-dose-interleukin-2-missed-its-main-survival-goal-a-biomarker-subgroup-did-better/2026-11-01weekly0.7https://jason-als.org/weeklyhttps://jason-als.org/about-als/weeklyhttps://jason-als.org/methodology/weeklyhttps://jason-als.org/privacy/weeklyhttps://jason-als.org/disclaimer/weeklyhttps://jason-als.org/contact/weekly